In Brief
Refine Search
Pharmaceutical
Privately-held Swiss firm Ferring Pharmaceuticals has entered into a new strategic collaboration in women’s health with the BioInnovation Institute (BII). 18 April 2023
Biosimilars
Israeli generics giant Teva Pharmaceutical Industries announced that the US Food and Drug Administration (FDA) has issued a complete response letter (CRL) to its partner Alvotech for the Biologics License Application (BLA) for AVT02, a high-concentration biosimilar candidate for AbbVie’s Humira (adalimumab). 14 April 2023
Biotechnology
Danish diabetes giant Novo Nordisk has raised its full-year sales and operating profit outlook, primarily reflecting robust sales of weight loss drug Wegovy (semaglutide). 13 April 2023
Pharmaceutical
Japanese companies Chugai and TwoCells have announced the termination of their collaboration for the investigational regenerative cellular medicine for knee chondrogenesis gMSC 1. 13 April 2023
Biotechnology
Swiss biotech Araris Biotech today announced that Samsung Venture Investment Corporation has invested in the company in an independent deal ahead of its on-going series A funding. 12 April 2023
Biotechnology
Chicago-based CTRL Therapeutics, a biotech company developing a cell therapy platform for solid tumors, today announced a $10 million seed financing led by General Catalyst with participation from Intermountain Health, FACIT and other investors. 11 April 2023
Biotechnology
Shares of US biotech Quince Therapeutics were down 5% at $1.44 in early trading today, after it announced that its board of directors has unanimously rejected the unsolicited proposal it received from Echo Lake Capital to acquire Quince for $1.60 per share in cash. 11 April 2023
Biotechnology
Japan’s Ono Pharmaceutical, US pharma major Bristol Myers Squibb and Dana-Farber Cancer Institute have entered into a global agreement to settle all disputes relating to the anti-PD-1/PD-L1 antibody patents recognized as the Honjo-Freeman Patents in the USA or the Honjo Patents in Japan. 11 April 2023
Biotechnology
Japanese drugmakers JCR Pharmaceuticals and Sumitomo Pharma have concluded a co-promotion agreement for Izcargo (pabinafusp alfa) IV Infusion 10mg in Japan. 7 April 2023
Biotechnology
ImmunoGen has entered into a term loan financing facility for up to $175 million with entities managed by Pharmakon Advisors. 6 April 2023
Pharmaceutical
The US Food and Drug Administration issued a draft guidance, “Patient-Focused Drug Development: Incorporating Clinical Outcome Assessments Into Endpoints for Regulatory Decision-Making 6 April 2023
Pharmaceutical
The UK's National Institute for Health and Care Excellence (NICE) has issued preliminary guidance which does not recommend Cabometyx (cabozantinib) for a specific use in thyroid cancer. 5 April 2023
Biotechnology
Denmark’s Adcendo has completed a series A extension financing, adding 31 million euros ($34 million) to the 51 million euros it raised in April 2021. 4 April 2023
Biotechnology
BioSenic, a Belgian biotech company specializing in serious autoimmune and inflammatory diseases and cell repair, has named Lieven Huysse, as permanent chief medical officer (CMO). 3 April 2023
Biotechnology
Following approval last month from the US regulator, Sandoz has now received European Commission (EC) marketing authorization in the European Union (EU) for a citrate-free high concentration formulation (HCF; 100mg/mL) of its biosimilar Hyrimoz (adalimumab), referencing 3 April 2023
Biotechnology
German family-owned pharma major Boehringer Ingelheim announced on Saturday that the US Centers for Medicare & Medicaid Services (CMS) has issued a permanent J-code (J1747) for Spevigo (spesolimab-sbzo) Injection, indicated 3 April 2023
Biosimilars
The Canadian territory of Yukon has become the 10th jurisdiction in Canada to announce a biosimilars switching policy. 31 March 2023
Biotechnology
Novozymes and Chr Hansen held their respective extraordinary general meetings, and the shareholders of both companies approved the proposed combination. 31 March 2023
Pharmaceutical
Massachusetts, USA-based precision medicine company FogPharma has appointed Mathai Mammen as chairman, president and chief executive. 30 March 2023
Pharmaceutical
Gaetan Leblay has been named vice president, customer and digital strategy for Europe, the Middle East and Africa at the Johnson & Johnson subsidiary Janssen. 30 March 2023
Biotechnology
Aizen Therapeutics, an AI-driven biotech headquartered in San Diego, has officially launched from stealth mode, introducing its drug discovery platform, DaX. 21 November 2024
Biotechnology
San Diego-based Valora Therapeutics, a biotech that boasts of having a novel approach to immunotherapy, has announced the successful closing of a $30 million seed funding round. 21 November 2024
Biotechnology
Astellas Pharma has been hit by bad news from the US Food and Drug Administration, which will not currently approve the firm’s request to supplement the label for Izervay (avacincaptad pegol). 21 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
Sage Therapeutics will down tools on its dalzanemdor program, after the Phase II DIMENSION trial missed both primary and secondary endpoints. 21 November 2024
Biotechnology
San Diego-based Kura Oncology and Japan’s Kyowa Kirin have entered into a global strategic collaboration to develop and commercialize ziftomenib. 21 November 2024
Biotechnology
HCW Biologics has announced a worldwide licensing agreement with WY Biotech to develop and commercialize one of its preclinical immunotherapy candidates. 21 November 2024
Pharmaceutical
Shanghai-based Leading Tac Pharmaceutical has announced the successful completion of a series A financing round, raising over 100 million yuan ($14 million). 21 November 2024
Biotechnology
Dutch clinical-stage biotech NewAmsterdam Pharma, which is focused on non-statin medicines for patients at risk of cardiovascular disease (CVD), has announced positive top-line data from its Phase III TANDEM clinical trial. 21 November 2024
Biotechnology
US biotech major Amgen has announced that Dr Howard Chang will join the company as senior vice president of research, effective December 16, 2024. 21 November 2024
Biotechnology
US clinical-stage biotech Vyriad has entered into a strategic collaboration with Swiss pharma giant Novartis to discover and develop in vivo chimeric antigen receptor (CAR) T-cell therapies. 21 November 2024
Biotechnology
The European Commission (EC) has granted marketing authorization for Hympavzi (marstacimab), from US pharma giant Pfizer. 20 November 2024
Biotechnology
Bioplatform company builder Flagship Pioneering has announced its companies Ampersand Biomedicines and Montai Therapeutics have entered into agreements to identify targeted molecules that could potentially be further developed as treatments for obesity and lung cancer. 20 November 2024
Pharmaceutical
Ascentage Pharma will see its investigational BCL-2 selective inhibitor, lisaftoclax, assessed under China’s Priority Review scheme. 20 November 2024
Biosimilars
Sweden-based Xbrane Biopharma and Intas Pharmaceuticals have announced an exclusive global licensing and co-development agreement for the former company’s Opdivo (nivolumab) biosimilar candidate. 20 November 2024
Biotechnology
A pair of industry veterans have teamed up to create Jupiter Bioventures, a San Francisco-based biotech venture foundry promised to build bold, science-driven therapeutics companies. 20 November 2024
Pharmaceutical
California, USA-based biotech Cytokinetics saw its shares fall as much as 4% to $9.67 yesterday, after it announced a deal with Germany’ Bayer. 20 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Biotechnology
The landscape of atopic dermatitis (AD) treatment is advancing with approvals of oral and topical Janus kinase (JAK) inhibitors across the seven major pharmaceutical markets (7MM; USA, France, Germany, Italy, Spain, UK and Japan). 20 November 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze